Greystone Financial Group’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-667
Closed -$311K 88
2025
Q4
$311K Sell
667
-39
-6% -$18.1K 0.05% 92
2025
Q3
$301K Sell
706
-72
-9% -$27.9K 0.05% 94
2025
Q2
$298K Sell
778
-66
-8% -$23.8K 0.05% 90
2025
Q1
$292K Sell
844
-93
-10% -$29.9K 0.05% 94
2024
Q4
$281K Hold
937
0.05% 91
2024
Q3
$381K Hold
937
0.07% 91
2024
Q2
$301K Sell
937
-365
-28% -$119K 0.06% 98
2024
Q1
$434K Hold
1,302
0.09% 88
2023
Q4
$352K Hold
1,302
0.08% 90
2023
Q3
$320K Hold
1,302
0.08% 88
2023
Q2
$395K Buy
+1,302
New +$362K 0.09% 89

Other funds holding HCA

Greystone Financial Group's HCA Position: Q1 2026 in Review

Greystone Financial Group sold out of HCA Healthcare (HCA) in Q1 2026, closing a stake of 667 shares — an estimated $311K sold.

Greystone Financial Group first reported a position in HCA in Q2 2023 and held it in 11 quarters. The position peaked at $434K in Q1 2024. 1,415 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Greystone Financial Group reported no remaining HCA Healthcare position as of Q1 2026 after selling out during the quarter.
  • Greystone Financial Group sold 667 HCA Healthcare shares in Q1 2026, an estimated $311K.
  • Greystone Financial Group first reported a position in HCA Healthcare in Q2 2023 and held it in 11 quarters.
  • Greystone Financial Group's HCA Healthcare position peaked at $434K in Q1 2024.
  • 1,415 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Greystone Financial Group's 13F filing for Q1 2026, filed 24 Apr 2026.